Union Science and Technology Minister Dr Jitendra Singh announced the setting up of Dr Rajendra Prasad Memorial Award in public administration in the field of academic excellence.
Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.